All In MedTech

Device Trial Radar · NCT04223830

Initial Case Series With Exalt Single-Use Duodenoscope - Expanded User Experience

Last checked: Nov 19, 2026Latest source record: Mar 31, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

200

Actual

Start

Jan 14, 2020

Primary completion

Feb 22, 2021

Study completion Mar 1, 2021

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Jan 10, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to confirm procedural performance of the Exalt Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures.

Conditions

  • Endoscopic Retrograde Cholangiopancreatography

Interventions

  • Exalt Model D Single-Use DuodenoscopeDevice

    Subjects will have a clinically indicated per standard of care endoscopic retrograde cholangiopancreatography (ERCP) or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Successful Endoscopic Retrograde Cholangiopancreatography (ERCP) ProcedureTime frame: Procedure success is assessed at the end of the procedure (within 24 hours on study day 1).

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California Los Angeles Medical Center

    Los Angeles, California

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.